Arm Shares Plunge 8% After Licensing Revenue Misses Estimates, Qualcomm Outlook Adds Pressure

Arm Holdings (ARM) shares tumbled 8% in after-hours trading on Wednesday following its fiscal third-quarter earnings report, as licensing revenue fell short of Wall Street expectations despite record overall revenue and strong royalty growth[1][3][4]. The sell-off was exacerbated by Qualcomm’s disappointing outlook, signaling potential headwinds for smartphone chip demand—a key market for Arm’s designs[4].

Mixed Q3 Results Spark Investor Concerns

Arm reported fiscal third-quarter revenue of $1.24 billion, up 26% year-over-year and beating analyst estimates of $1.23 billion[1][4]. Adjusted earnings per share came in at 43 cents, surpassing FactSet consensus of 41 cents, while GAAP profit was $223 million or 21 cents per share, down from $252 million a year earlier[1].

Royalty revenue shone brightly, climbing 27% to $737 million, driven by higher royalty rates per chip and surging adoption in AI data centers[1][4]. This segment exceeded estimates of $707.9 million, underscoring Arm’s pivotal role in the AI boom where its power-efficient architectures power chips from Nvidia, Amazon, and others[3][4].

However, licensing revenue disappointed at $505 million, slightly below the $519.9 million expected by analysts[4]. Licensing—Arm’s high-margin business selling processor blueprints to tech giants like Apple and Qualcomm—signals upfront demand for new designs. The miss raised red flags about slowing adoption of next-generation architectures, even as Arm pushes customers toward higher-cost versions[3][4].

Shares closed the regular session before plunging 8.3% to $96.12 in after-hours, reflecting a stark 35% decline over the past year amid broader semiconductor volatility[1]. From a 52-week high of $183.16 in October 2025, the stock is down 42.5%, trading at a lofty 122.75 times forward earnings despite year-to-date losses of 3.6%[2].

Forward Guidance Offers Some Reassurance, But Seasonality Looms

Looking ahead, Arm guided for fourth-quarter revenue growth of about 18% to around $1.47 billion, topping LSEG estimates of $1.44 billion[1][4]. Royalty revenue is projected to rise in the low-teens percentage, decelerating from 27% in Q3 due to typical seasonality[1].

CEO Rene Haas emphasized unrelenting AI demand, stating it’s “beyond no end in sight” for designs handling data flows in AI systems[4]. Arm’s architectures are increasingly vital for AI agents on PCs and online tasks, as well as energy-efficient data center servers managing Nvidia GPU workloads[4].

Yet, the guidance failed to fully offset licensing woes. Analysts like Summit Insights’ Kinngai Chan noted the miss directly fueled the sell-off[4].

Qualcomm’s Shadow and Broader Headwinds

The timing amplified pressure from Qualcomm’s bleak outlook. The chip supplier forecasted results below estimates, citing a global memory supply shortage that could crimp mobile phone sales[4]. Smartphones remain a cornerstone for Arm, and memory cost spikes pose a “headwind,” per Chan[4].

Compounding this is Arm’s ongoing legal battle with Qualcomm over licensing terms. Qualcomm challenges Arm’s right to cancel its architecture license amid its AI chip push for PCs and phones, casting uncertainty over future royalties and licensing[3]. This dispute magnifies any licensing weakness, eroding confidence in Arm’s moat[3].

Macro factors weigh heavily too. BofA recently downgraded Arm to Neutral with a $120 target, citing smartphone unit declines, SoftBank reliance, and limited AI royalty exposure[2]. Despite this, consensus remains “Moderate Buy” from 31 analysts: 18 Strong Buys, one Moderate Buy, 11 Holds, and one Strong Sell. Average target of $164.27 implies 53.6% upside, with a high of $215[2].

Susquehanna’s Positive upgrade to $150 highlights AI momentum, but near-term volatility persists[2].

Arm’s AI Bet Amid Volatility

Arm’s business model—licensing IP plus per-chip royalties—positions it uniquely in semiconductors without fabrication costs. Q2 FY26 set a record at $1.14 billion (up 34%), marking three quarters above $1 billion[2]. AI validation comes from Nvidia’s Grace CPU and hyperscalers’ custom silicon[4].

Still, the licensing stutter reveals vulnerabilities. Investors betting on endless AI growth got a reality check: royalties thrive on current shipments, but licensing forecasts future ramps[3]. With shares down sharply from peaks, the post-earnings plunge tests conviction.

For long-term holders, Arm’s AI centrality endures. Demand for efficient chips in data centers, edge devices, and AI agents shows no signs of abating[1][4]. Short-term, Qualcomm friction and memory woes could prolong pain, especially if smartphone weakness deepens.

Arm stock fans should monitor Q4 execution and legal updates. At current levels, the pullback offers entry for believers in Arm’s IP dominance, but caution reigns amid mixed signals[2].

(Word count: 812)

Original source: CNBC Business – Shares of Arm plunge 8% after licensing revenue misses estimates, Qualcomm outlook adds pressure